Related Experiment Video
Updated: Sep 9, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
A Feature-Augmented Explainable Artificial Intelligence Model for Diagnosing Alzheimer's Disease from Multimodal
Fatima Hasan Al-Bakri1, Wan Mohd Yaakob Wan Bejuri1,2, Mohamed Nasser Al-Andoli3
1Faculty of Information and Communication Technology, Universiti Teknikal Malaysia Melaka, Melaka 76100, Malaysia.
Diagnostics (Basel, Switzerland)
|August 28, 2025
Summary
This study evaluated an explainable AI approach for Alzheimer's disease (AD) diagnosis. Expert clinicians found the AI
Area of Science:
- Artificial Intelligence in Medicine
- Neuroscience
- Medical Imaging Analysis
Background:
- Alzheimer's disease (AD) diagnosis requires integrating complex data like clinical information, cognitive scores (MMSE), and MRI scans.
- Current AI diagnostic tools often lack transparency, hindering clinical adoption.
- Explainable AI (XAI) methods are crucial for building trust and facilitating the use of AI in healthcare.
Purpose of the Study:
- To evaluate a Feature-Augmented explainable AI (XAI) approach for supporting Alzheimer's disease (AD) diagnosis.
- To assess the impact of AI explainability on clinician trust and understanding in AD diagnosis.
- To integrate clinical data, MMSE scores, and MRI scans within an XAI framework.
Main Methods:
- A survey-based evaluation involving five experienced physicians specializing in AD.
- Participants assessed AI-generated diagnostic outputs, including clinical feature interpretations, MRI heat maps, and combined explanations.
- The XAI approach combined rule-based reasoning with example-based visualization for enhanced interpretability.
Main Results:
- The explainable AI model achieved a 100% trust score among participating clinicians.
- 80% of clinicians expressed conditional trust, indicating a need for further clarification alongside AI insights.
- The integrated explanation format significantly improved clinician understanding and confidence in AI-assisted AD diagnosis.
Conclusions:
- This study is the first to gather expert clinician feedback on an XAI model for AD diagnosis.
- Explainability is a critical factor in fostering trust and usability of AI tools in clinical practice.
- XAI approaches are particularly valuable for supporting experienced clinicians in complex diagnostic tasks like AD.
Related Concept Videos
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260

